Article
Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.
American journal of human genetics - 1 Jun 2004
van der Walt Joelle M, Noureddine Maher A, Kittappa Raja, Hauser Michael A, Scott William K, McKay Ron, Zhang Fengyu, Stajich Jeffrey M, Fujiwara Kenichiro, Scott Burton L, Pericak-Vance Margaret A, Vance Jeffery M, Martin Eden R
Abstract excerpt
The pathogenic process responsible for the loss of dopaminergic neurons within the substantia nigra of patients with Parkinson disease (PD) is poorly understood. Current research supports the involvement of fibroblast growth factor (FGF20) in the survival of dopaminergic cells. FGF20 is a neurotrophic factor that is preferentially expressed within the substantia nigra of rat brain. The human homologue has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
